Federal Register / Vol. 70, No. 225 / Wednesday, November 23, 2005 / Notices 70855 

and for verification purposes, the 

subject individual’s name (woman’s 

maiden name, if applicable). Furnishing 

the SSN is voluntary, but it may make 

searching for a record easier and prevent 

delay. 

RECORD ACCESS PROCEDURE: 

For purpose of access, use the same 

procedures outlined in Notification 

Procedures above. Requestors should 

also reasonably specify the record 

contents being sought. (These 

procedures are in accordance with 

Department regulation 45 CFR 

5b.5(a)(2)). 

CONTESTING RECORD PROCEDURES: 

The subject individual should contact 

the system manager named above, and 

reasonably identify the record and 

specify the information to be contested. 

State the corrective action sought and 

the reasons for the correction with 

supporting justification. (These 

procedures are in accordance with 

Department regulation 45 CFR 5b.7). 

RECORD SOURCE CATEGORIES: 

Information contained in this system 

will be submitted by NDMS hospitals, 

other providers, and States. 

SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS

OF THE ACT: 

None. 

[FR Doc. 05–23239 Filed 11–22–05; 8:45 am] 

BILLING CODE 4120–03–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the meeting of the 

Advisory Committee to the Director, 

National Institutes of Health (NIH). 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

A portion of the meeting will be 

closed to the public in accordance with 

the provisions set forth in sections 

552b(c)(6) and 552b(c)(9)(B), title 5 

U.S.C., as amended, because the 

disclosure of which would constitute a 

clearly unwarranted invasion of 

personal privacy and the premature 

disclosure of information and the 

discussions would likely significantly 

frustrate implementation of the 

program. 

Name of Committee: Advisory Committee 

to the Director, NIH. 

Date: December 1–2, 2005. 

Open: December 1, 2005, 8:30 a.m. to 4:30 

p.m. 

Agenda: Among the topics proposed for 

discussion are: (1) NIH Director’s Report; (2) 

Clinical and Translational Science Awards; 

(3) NIH Director’s Council of Public 

Representatives Liaison Report; and(4) 

update on NIH Neurosciences Blueprint. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, Conference 

Room 6, Bethesda, MD 20892. 

Closed: December 2, 2005, 8:30 a.m. to 10 

a.m. 

Agenda: Office of Portfolio Analysis and 

Strategic Initiatives (OPASI). 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, Conference 

Room 6, Bethesda, MD 20892. 

Open: December 2, 2005, 10 a.m. to 12 p.m. 

Agenda: Among the topics proposed for 

discussion are: (1) Public Access Update; and 

(2) Workgroup Report on Outside Awards for 

NIH Employees. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, Conference 

Room 6, Bethesda, MD 20892. 

Contact Person: Shelly Pollard, ACD 

Coordinator, Office of Communications and 

Public Liaison, Office of the Director, 

National Institutes of Health, 31 Center Drive, 

Building 31, Room 5B64, Bethesda, MD 

20892, Phone: (301) 496–0959, 

pollards@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

into the building by non-government 

employees. Persons without a government 

I.D. will need to show a photo I.D. and sign 

in at the security desk upon entering the 

building. 

Information is also available on the 

Institute’s/Center’s Home page: http:// 

www.nih.gov/about/director/acd.htm, where 

an agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: November 7, 2005. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–23188 Filed 11–22–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Initial Review Group, Subcommittee 

D—Clinical Studies. 

Date: December 13–14, 2005. 

Time: 9 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda North Hotel & 

Conference Center, 5701 Marinelli Road, 

North Bethesda, MD 20852. 

Contact Person: William D. Merritt, PhD, 

Scientific Review Administrator, Research 

Programs Review Branch, National Cancer 

Institute, Division of Extramural Activities, 

6116 Executive Blvd., 8th Floor, Bethesda, 

MD 20892–8328, 301–496–9767, 

wm63f@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 39.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: November 8, 2005. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–23193 Filed 11–22–05; 8:45 am] 

BILLING CODE 4140–01–M